To develop an automated RCC grading system that balances high predictive power with simplicity, interpretability, and robustness against domain variations, ensuring clinical applicability.
Key Findings:
The hybrid model achieved performance comparable to transformer-based and nuclei-centric methods.
Explicit tumor segmentation improved grading reliability across multi-institutional datasets.
The model demonstrated reduced computational complexity and inference time, with specific metrics to be detailed.
Interpretation:
The study suggests that a well-optimized convolutional pipeline can effectively automate RCC grading while addressing practical limitations faced in clinical settings, potentially improving patient outcomes.
Limitations:
The study may not account for all variations in staining protocols and tissue preparation across different institutions.
Further validation is needed to confirm the model's performance in diverse clinical environments, and potential biases in data selection or model training should be considered.
Conclusion:
The proposed hybrid DenseNet-U-Net model represents a promising approach for automated RCC grading, balancing accuracy and practicality for clinical use, while addressing the need for reliability in real-world applications.
